QXO (QXO) had the highest return in 2012 by a US stock with a market cap of $1B+, returning 1,151,950%.
| ASSET | YEAR | % RETURN |
|---|---|---|
QXO (QXO) | 2012 | 1,151,950% |
Par Pacific (PARR) | 2012 | 1,900% |
Sarepta Therapeutics (SRPT) | 2012 | 469.54% |
BioLife Solutions (BLFS) | 2012 | 325% |
ACADIA Pharmaceuticals (ACAD) | 2012 | 322.73% |
Harrow Health (HROW) | 2012 | 306.25% |
Patrick Industries (PATK) | 2012 | 276.75% |
Astrana Health (ASTH) | 2012 | 237.84% |
MiMedx (MDXG) | 2012 | 233.91% |
Regeneron Pharmaceuticals (REGN) | 2012 | 202.73% |
Vipshop (VIPS) | 2012 | 197.32% |
PulteGroup (PHM) | 2012 | 180.68% |
HCI (HCI) | 2012 | 176.84% |
Builders FirstSource (BLDR) | 2012 | 165.71% |
M/I Homes (MHO) | 2012 | 165.53% |
American Airlines (AAL) | 2012 | 159.62% |
Radian (RDN) | 2012 | 158.62% |
Celldex Therapeutics (CLDX) | 2012 | 153.21% |
CVR Energy (CVI) | 2012 | 152.8% |
Himax Technologies (HIMX) | 2012 | 146.61% |
IES (IESC) | 2012 | 146.58% |
Sharplink Gaming (SBET) | 2012 | 144.83% |
Grifols SA ADR (GRFS) | 2012 | 143.09% |
Marriot Vacations Worldwide (VAC) | 2012 | 138.8% |
Acadia Healthcare (ACHC) | 2012 | 137.78% |
